Cancer predisposing BARD1 mutations in breast-ovarian cancer families

Breast Cancer Research and Treatment

Volumn 131, Issue 1, 2012, Pages 89-97

  Ratajska, Magdalena ^a   Antoszewska, Ewelina ^a   Piskorz, Anna ^a   Brozek, Izabela ^a,b   Borg, Åke ^c   Kusmierek, Hanna ^d   Biernat, Wojciech ^a   Limon, Janusz ^a,b  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Regional Oncological Outpatient Clinic   (Poland)

^c LUND UNIVERSITY   (Sweden)

^d UNIVERSITY OF GDA SK   (Poland)

Author keywords

BARD1 mutation; Breast cancer; Hereditary; Ovarian cancer

Indexed keywords

ADULT; AGED; ARTICLE; BARD1 GENE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONSENSE MUTATION; NUCLEOTIDE SEQUENCE; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; TUMOR GENE;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE; SEQUENCE ANALYSIS, DNA; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 84856210264     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1403-8     Document Type: Article

References (61)

1. AC Antoniou PD Pharoah G McMullan NE Day BA Ponder D Easton 2001 Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study Genet Epidemiol 21 1 18 10.1002/gepi.1014 11443730 10.1002/gepi.1014 1:STN:280:DC%2BD3MzovVGltQ%3D%3D (Pubitemid 32619211)
2. AC Antoniou PD Pharoah G McMullan NE Day MR Stratton J Peto BJ Ponder DF Easton 2002 A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes Br J Cancer 86 76 83 10.1038/sj.bjc.6600008 11857015 10.1038/sj.bjc.6600008 1:STN:280:DC%2BD387isV2jtw%3D%3D (Pubitemid 34146344)
3. K Arnold L Bordoli J Kopp T Schwede 2006 The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling Bioinformatics 22 195 201 10.1093/bioinformatics/bti770 16301204 10.1093/bioinformatics/bti770 1:CAS:528:DC%2BD28XovVCltw%3D%3D (Pubitemid 43205406)
4. E Ars H Kruyer A Gaona E Serra C Lazaro X Estivill 1999 Prenatal diagnosis of sporadic neurofibromatosis type 1 (NF1) by RNA and DNA analysis of a splicing mutation Prenat Diagn 19 739 742 10451518 10.1002/(SICI)1097- 0223(199908)19:8<739::AID-PD626>3.0.CO;2-A 1:CAS:528:DyaK1MXlvF2gtbc%3D (Pubitemid 29385403)
5. TC Ayi JT Tsan LY Hwang AM Bowcock R Baer 1998 Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein Oncogene 17 2143 2148 10.1038/sj.onc.1202123 9798686 10.1038/sj.onc.1202123 1:CAS:528:DyaK1cXnt1GltLc%3D (Pubitemid 28499341)
6. D Baralle M Baralle 2005 Splicing in action: assessing disease causing sequence changes J Med Genet 42 737 748 10.1136/jmg.2004.029538 16199547 10.1136/jmg.2004.029538 1:CAS:528:DC%2BD2MXhtFyhu7bL (Pubitemid 41475248)
7. M Baralle N Skoko A Knezevich L De Conti D Motti M Bhuvanagiri D Baralle E Buratti FE Baralle 2006 NF1 mRNA biogenesis: effect of the genomic milieu in splicing regulation of the NF1 exon 37 region FEBS Lett 580 4449 4456 10.1016/j.febslet.2006.07.018 16870183 10.1016/j.febslet.2006.07.018 1:CAS:528:DC%2BD28Xns12lsb0%3D (Pubitemid 44118266)
8. SB Cantor DW Bell S Ganesan EM Kass R Drapkin S Grossman DC Wahrer DC Sgroi WS Lane DA Haber DM Livingston 2001 BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function Cell 105 149 160 11301010 10.1016/S0092-8674(01)00304-X 1:CAS:528: DC%2BD3MXivFOjtrg%3D (Pubitemid 32323924)
9. M Caputi RJ Kendzior Jr. KL Beemon 2002 A nonsense mutation in the fibrillin-1 gene of a Marfan syndrome patient induces NMD and disrupts an exonic splicing enhancer Genes Dev 16 1754 1759 10.1101/gad.997502 12130535 10.1101/gad.997502 1:CAS:528:DC%2BD38Xls1Onur0%3D (Pubitemid 34803891)
10. L Cartegni AR Krainer 2002 Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 Nat Genet 30 377 384 10.1038/ng854 11925564 10.1038/ng854 1:CAS:528: DC%2BD38Xisl2lsLo%3D
11. L Cartegni J Wang Z Zhu MQ Zhang AR Krainer 2003 ESEfinder: a web resource to identify exonic splicing enhancers Nucleic Acids Res 31 3568 3571 12824367 10.1093/nar/gkg616 1:CAS:528:DC%2BD3sXltVWisLw%3D (Pubitemid 37442199)
12. S De Brakeleer J De Greve R Loris N Janin W Lissens E Sermijn E Teugels 2010 Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families Hum Mutat 31 E1175 E1185 10.1002/humu.21200 20077502 10.1002/humu.21200
13. JT den Dunnen SE Antonarakis 2000 Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion Hum Mutat 15 7 12 10.1002/(sici)1098-1004(200001)15:1<7::aid-humu4>3.0.co;2-n 10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N (Pubitemid 30036162)
14. FO Desmet D Hamroun M Lalande G Collod-Beroud M Claustres C Beroud 2009 Human Splicing Finder: an online bioinformatics tool to predict splicing signals Nucleic Acids Res 37 e67 10.1093/nar/gkp215 19339519 10.1093/nar/gkp215
15. DF Easton 1999 How many more breast cancer predisposition genes are there? Breast Cancer Res 1 14 17 11250676 10.1186/bcr6 1:CAS:528: DC%2BD3cXlsFKgs7s%3D (Pubitemid 32223529)
16. H Erkko B Xia J Nikkila J Schleutker K Syrjakoski A Mannermaa A Kallioniemi K Pylkas SM Karppinen K Rapakko A Miron Q Sheng G Li H Mattila DW Bell DA Haber M Grip M Reiman A Jukkola-Vuorinen A Mustonen J Kere LA Aaltonen VM Kosma V Kataja Y Soini RI Drapkin DM Livingston R Winqvist 2007 A recurrent mutation in PALB2 in Finnish cancer families Nature 446 316 319 10.1038/nature05609 17287723 10.1038/nature05609 1:CAS:528:DC%2BD2sXivVSns78%3D (Pubitemid 46426155)
17. JD Fackenthal L Cartegni AR Krainer OI Olopade 2002 BRCA2 T2722R is a deleterious allele that causes exon skipping Am J Hum Genet 71 625 631 10.1086/342192 12145750 10.1086/342192 1:CAS:528:DC%2BD38XmvFOhtbk%3D (Pubitemid 34970133)
18. D Fox 3rd I Le Trong P Rajagopal PS Brzovic RE Stenkamp RE Klevit 2008 Crystal structure of the BARD1 ankyrin repeat domain and its functional consequences J Biol Chem 283 21179 21186 10.1074/jbc.M802333200 18480049 10.1074/jbc.M802333200 1:CAS:528:DC%2BD1cXoslWrtb4%3D
19. C Ghimenti E Sensi S Presciuttini IM Brunetti P Conte G Bevilacqua MA Caligo 2002 Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations Genes Chromosomes Cancer 33 235 242 11807980 10.1002/gcc.1223 1:CAS:528:DC%2BD38XhvF2ktrc%3D (Pubitemid 34130929)
20. KL Gorringe DY Choong JE Visvader GJ Lindeman IG Campbell 2008 BARD1 variants are not associated with breast cancer risk in Australian familial breast cancer Breast Cancer Res Treat 111 505 509 10.1007/s10549-007-9799-x 17972171 10.1007/s10549-007-9799-x 1:CAS:528:DC%2BD1cXhtV2js7bK
21. SM Hebsgaard PG Korning N Tolstrup J Engelbrecht P Rouze S Brunak 1996 Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information Nucleic Acids Res 24 3439 3452 8811101 10.1093/nar/24.17.3439 1:CAS:528:DyaK28XlvVGrs7s%3D (Pubitemid 26294458)
22. IA Hedenfalk M Ringner JM Trent A Borg 2002 Gene expression in inherited breast cancer Adv Cancer Res 84 1 34 11883525 10.1016/S0065-230X(02)84001-5 1:CAS:528:DC%2BD38XlsVWqsbc%3D (Pubitemid 34188192)
23. K Heikkinen SM Karppinen Y Soini M Makinen R Winqvist 2003 Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility J Med Genet 40 e131 14684699 10.1136/jmg.40.12. e131 1:STN:280:DC%2BD3sngt1ChtQ%3D%3D
24. I Irminger-Finger WC Leung 2002 BRCA1-dependent and independent functions of BARD1 Int J Biochem Cell Biol 34 582 587 11943588 10.1016/S1357-2725(01) 00161-3 1:CAS:528:DC%2BD38Xis1CqsL8%3D (Pubitemid 34270710)
25. M Ishitobi Y Miyoshi S Hasegawa C Egawa Y Tamaki M Monden S Noguchi 2003 Mutational analysis of BARD1 in familial breast cancer patients in Japan Cancer Lett 200 1 7 14550946 10.1016/S0304-3835(03)00387-2 1:CAS:528: DC%2BD3sXnvFShtLg%3D (Pubitemid 37222352)
26. A Jakubowska C Cybulski A Szymanska T Huzarski T Byrski J Gronwald T Debniak B Gorski E Kowalska SA Narod J Lubinski 2008 BARD1 and breast cancer in Poland Breast Cancer Res Treat 107 119 122 10.1007/s10549-007-9537-4 17333333 10.1007/s10549-007-9537-4 1:CAS:528:DC%2BD2sXhtlGrtbrN (Pubitemid 350179597)
27. CE Jefford A Feki J Harb KH Krause I Irminger-Finger 2004 Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity Oncogene 23 3509 3520 10.1038/sj.onc.1207427 15077185 10.1038/sj.onc.1207427 1:CAS:528:DC%2BD2cXjsV2ntbo%3D (Pubitemid 38658417)
28. SM Karppinen K Heikkinen K Rapakko R Winqvist 2004 Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer J Med Genet 41 e114 10.1136/jmg.2004.020669 15342711 10.1136/jmg.2004.020669
29. AG Lewis J Flanagan A Marsh GM Pupo G Mann AB Spurdle GJ Lindeman JE Visvader MA Brown G Chenevix-Trench 2005 Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer Breast Cancer Res 7 R1005 R1016 10.1186/bcr1336 16280053 10.1186/bcr1336 1:CAS:528:DC%2BD2MXht1WmsrjL
30. L Li M Cohen J Wu MH Sow B Nikolic P Bischof I Irminger-Finger 2007 Identification of BARD1 splice-isoforms involved in human trophoblast invasion Int J Biochem Cell Biol 39 1659 1672 10.1016/j.biocel.2007.04.018 17556008 10.1016/j.biocel.2007.04.018 1:CAS:528:DC%2BD2sXot12ltrk%3D (Pubitemid 47090213)
31. L Li S Ryser E Dizin D Pils M Krainer CE Jefford F Bertoni R Zeillinger I Irminger-Finger 2007 Oncogenic BARD1 isoforms expressed in gynecological cancers Cancer Res 67 11876 11885 10.1158/0008-5472.CAN-07-2370 18089818 10.1158/0008-5472.CAN-07-2370 1:CAS:528:DC%2BD2sXhsVCjs7nO
32. HX Liu L Cartegni MQ Zhang AR Krainer 2001 A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes Nat Genet 27 55 58 10.1038/83762 11137998 1:CAS:528:DC%2BD3MXis1yktg%3D%3D (Pubitemid 32044518)
33. ST Marquis JV Rajan A Wynshaw-Boris J Xu GY Yin KJ Abel BL Weber LA Chodosh 1995 The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues Nat Genet 11 17 26 10.1038/ng0995-17 7550308 10.1038/ng0995-17 1:CAS:528:DyaK2MXnvFels7c%3D
34. EE McCarthy JT Celebi R Baer T Ludwig 2003 Loss of Bard1, the heterodimeric partner of the Brca1 tumor suppressor, results in early embryonic lethality and chromosomal instability Mol Cell Biol 23 5056 5063 12832489 10.1128/MCB.23.14.5056-5063.2003 1:CAS:528:DC%2BD3sXltleksr0%3D (Pubitemid 36793349)
35. H Meijers-Heijboer A van den Ouweland J Klijn M Wasielewski A de Snoo R Oldenburg A Hollestelle M Houben E Crepin M van Veghel-Plandsoen F Elstrodt C van Duijn C Bartels C Meijers M Schutte L McGuffog D Thompson D Easton N Sodha S Seal R Barfoot J Mangion J Chang-Claude D Eccles R Eeles DG Evans R Houlston V Murday S Narod T Peretz J Peto C Phelan HX Zhang C Szabo P Devilee D Goldgar PA Futreal KL Nathanson B Weber N Rahman MR Stratton 2002 Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations Nat Genet 31 55 59 10.1038/ng879 11967536 10.1038/ng879 1:CAS:528:DC%2BD38Xjt1Kns78%3D
36. JE Meza PS Brzovic MC King RE Klevit 1999 Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1 J Biol Chem 274 5659 5665 10026184 10.1074/jbc.274.9.5659 1:CAS:528:DyaK1MXhsFaqtLg%3D (Pubitemid 29109218)
37. Y Miki J Swensen D Shattuck-Eidens PA Futreal K Harshman S Tavtigian Q Liu C Cochran LM Bennett W Ding, et al. 1994 A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 266 66 71 7545954 10.1126/science.7545954 1:CAS:528:DyaK2MXhtF2ns70%3D (Pubitemid 24345325)
38. M Mosor I Ziolkowska-Suchanek K Roznowski M Baranowska D Januszkiewicz-Lewandowska J Nowak 2010 RAD50 gene mutations are not likely a risk factor for breast cancer in Poland Breast Cancer Res Treat 123 607 609 10.1007/s10549-010-0992-y 20571869 10.1007/s10549-010-0992-y
39. PC Ng S Henikoff 2001 Predicting deleterious amino acid substitutions Genome Res 11 863 874 10.1101/gr.176601 11337480 10.1101/gr.176601 1:CAS:528:DC%2BD3MXjs1Wmu7w%3D (Pubitemid 32447869)
40. PD Pharoah A Antoniou M Bobrow RL Zimmern DF Easton BA Ponder 2002 Polygenic susceptibility to breast cancer and implications for prevention Nat Genet 31 33 36 10.1038/ng853 11984562 10.1038/ng853 1:CAS:528: DC%2BD38Xjt1Kgu7g%3D
41. PD Pharoah AC Antoniou DF Easton BA Ponder 2008 Polygenes, risk prediction, and targeted prevention of breast cancer N Engl J Med 358 2796 2803 10.1056/NEJMsa0708739 18579814 10.1056/NEJMsa0708739 1:CAS:528: DC%2BD1cXnvFamt7Y%3D (Pubitemid 351930854)
42. BA Ponder 2001 Cancer genetics Nature 411 336 341 10.1038/35077207 11357140 10.1038/35077207 1:CAS:528:DC%2BD3MXktVSjsr4%3D (Pubitemid 32467042)
43. N Rahman S Seal D Thompson P Kelly A Renwick A Elliott S Reid K Spanova R Barfoot T Chagtai H Jayatilake L McGuffog S Hanks DG Evans D Eccles DF Easton MR Stratton 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 165 167 10.1038/ng1959 17200668 10.1038/ng1959 1:CAS:528:DC%2BD2sXpvFeqsw%3D%3D (Pubitemid 46184346)
44. V Ramensky P Bork S Sunyaev 2002 Human non-synonymous SNPs: server and survey Nucleic Acids Res 30 3894 3900 12202775 10.1093/nar/gkf493 1:CAS:528:DC%2BD38Xms1Klt7k%3D (Pubitemid 35012462)
45. MG Reese FH Eeckman D Kulp D Haussler 1997 Improved splice site detection in Genie J Comput Biol 4 311 323 9278062 10.1089/cmb.1997.4.311 1:CAS:528:DyaK2sXls1Whtbc%3D (Pubitemid 27355870)
46. A Renwick D Thompson S Seal P Kelly T Chagtai M Ahmed B North H Jayatilake R Barfoot K Spanova L McGuffog DG Evans D Eccles DF Easton MR Stratton N Rahman 2006 ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 873 875 10.1038/ng1837 16832357 10.1038/ng1837 1:CAS:528:DC%2BD28XnsVChu7Y%3D (Pubitemid 44141653)
47. JA Rodriguez S Schuchner WW Au M Fabbro BR Henderson 2004 Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1 Oncogene 23 1809 1820 10.1038/sj.onc.1207302 14647430 10.1038/sj.onc.1207302 1:CAS:528: DC%2BD2cXhvFOiurk%3D (Pubitemid 38445406)
48. R Sabatier J Adelaide P Finetti A Ferrari L Huiart H Sobol M Chaffanet D Birnbaum F Bertucci 2010 BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer Genes Chromosomes Cancer 49 1143 1151 10.1002/gcc.20822 20842729 10.1002/gcc.20822 1:CAS:528:DC%2BC3cXhsVGhtrbL
49. MK Sauer IL Andrulis 2005 Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer J Med Genet 42 633 638 10.1136/jmg.2004.030049 16061562 10.1136/jmg.2004.030049 1:CAS:528:DC%2BD2MXhtVSltrjI (Pubitemid 41129035)
50. S Seal D Thompson A Renwick A Elliott P Kelly R Barfoot T Chagtai H Jayatilake M Ahmed K Spanova B North L McGuffog DG Evans D Eccles DF Easton MR Stratton N Rahman 2006 Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 1239 1241 10.1038/ng1902 17033622 10.1038/ng1902 1:CAS:528:DC%2BD28XhtFeisbjJ (Pubitemid 44646283)
51. SG Sedgwick SJ Smerdon 1999 The ankyrin repeat: a diversity of interactions on a common structural framework Trends Biochem Sci 24 311 316 10431175 10.1016/S0968-0004(99)01426-7 1:CAS:528:DC%2BD3cXjtVKqsQ%3D%3D (Pubitemid 29366805)
52. PJ Smith C Zhang J Wang SL Chew MQ Zhang AR Krainer 2006 An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers Hum Mol Genet 15 2490 2508 10.1093/hmg/ddl171 16825284 10.1093/hmg/ddl171 1:CAS:528:DC%2BD28XotlaisL4%3D (Pubitemid 44288702)
53. J Steffen R Varon M Mosor G Maneva M Maurer M Stumm D Nowakowska M Rubach E Kosakowska W Ruka Z Nowecki P Rutkowski T Demkow M Sadowska M Bidzinski K Gawrychowski K Sperling 2004 Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland Int J Cancer 111 67 71 10.1002/ijc.20239 15185344 10.1002/ijc.20239 1:CAS:528:DC%2BD2cXlsFWrtLs%3D (Pubitemid 38859284)
54. J Steffen D Nowakowska A Niwinska D Czapczak A Kluska M Piatkowska A Wisniewska Z Paszko 2006 Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland Int J Cancer 119 472 475 10.1002/ijc.21853 16770759 10.1002/ijc.21853 1:CAS:528: DC%2BD28XmsVOjur4%3D
55. M Swift D Morrell RB Massey CL Chase 1991 Incidence of cancer in 161 families affected by ataxia-telangiectasia N Engl J Med 325 1831 1836 10.1056/nejm199112263252602 1961222 10.1056/NEJM199112263252602 1:STN:280:DyaK38%2Fnt1KgsA%3D%3D
56. M Szybka I Zawlik D Kulczycka E Golanska E Jesien D Kupnicka R Stawski S Piaskowski E Bieniek M Zakrzewska R Kordek PP Liberski P Rieske 2008 Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53 Br J Cancer 98 1431 1433 10.1038/sj.bjc.6604258 18349850 10.1038/sj.bjc.6604258 1:CAS:528:DC%2BD1cXks12gtbk%3D (Pubitemid 351543567)
57. SN Teraoka M Telatar S Becker-Catania T Liang S Onengut A Tolun L Chessa O Sanal E Bernatowska RA Gatti P Concannon 1999 Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences Am J Hum Genet 64 1617 1631 10.1086/302418 10330348 10.1086/302418 1:CAS:528: DyaK1MXltlOgtbg%3D (Pubitemid 30481513)
58. TH Thai F Du JT Tsan Y Jin A Phung MA Spillman HF Massa CY Muller R Ashfaq JM Mathis DS Miller BJ Trask R Baer AM Bowcock 1998 Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers Hum Mol Genet 7 195 202 9425226 10.1093/hmg/7.2.195 1:CAS:528:DyaK1cXpvFSlsg%3D%3D (Pubitemid 28048534)
59. P Vahteristo K Syrjakoski T Heikkinen H Eerola K Aittomaki K von Smitten K Holli C Blomqvist OP Kallioniemi H Nevanlinna 2006 BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition Eur J Hum Genet 14 167 172 10.1038/sj.ejhg.5201542 16333312 10.1038/sj.ejhg.5201542 1:CAS:528: DC%2BD28Xlt1emsw%3D%3D (Pubitemid 43135859)
60. T Walsh MC King 2007 Ten genes for inherited breast cancer Cancer Cell 11 103 105 10.1016/j.ccr.2007.01.010 17292821 10.1016/j.ccr.2007.01.010 1:CAS:528:DC%2BD2sXitVartLw%3D (Pubitemid 46209856)
61. LC Wu ZW Wang JT Tsan MA Spillman A Phung XL Xu MC Yang LY Hwang AM Bowcock R Baer 1996 Identification of a RING protein that can interact in vivo with the BRCA1 gene product Nat Genet 14 430 440 10.1038/ng1296-430 8944023 10.1038/ng1296-430 1:CAS:528:DyaK28XntlGgsbg%3D (Pubitemid 26414587)